<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33630959</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>e0247841</StartPage><MedlinePgn>e0247841</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0247841</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0247841</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is the most frequent motor neuron disorder, with a significant social and economic burden. ALS remains incurable, and the only drugs approved for its treatments confers a survival benefit of a few months for the patients. Missense mutations in superoxide dismutase 1 (SOD1), a major cytoplasmic antioxidant enzyme, has been associated with ALS development, accounting for 23% of its familial cases and 7% of all sporadic cases. This work aims to characterize in silico the structural and functional effects of SOD1 protein variants. Missense mutations in SOD1 were compiled from the literature and databases. Twelve algorithms were used to predict the functional and stability effects of these mutations. ConSurf was used to estimate the evolutionary conservation of SOD1 amino-acids. GROMACS was used to perform molecular dynamics (MD) simulations of SOD1 wild-type and variants A4V, D90A, H46R, and I113T, which account for approximately half of all ALS-SOD1 cases in the United States, Europe, Japan, and United Kingdom, respectively. 233 missense mutations in SOD1 protein were compiled from the databases and literature consulted. The predictive analyses pointed to an elevated rate of deleterious and destabilizing predictions for the analyzed variants, indicating their harmful effects. The ConSurf analysis suggested that mutations in SOD1 mainly affect conserved and possibly functionally essential amino acids. The MD analyses pointed to flexibility and essential dynamics alterations at the electrostatic and metal-binding loops of variants A4V, D90A, H46R, and I113T that could lead to aberrant interactions triggering toxic protein aggregation. These alterations may have harmful implications for SOD1 and explain their association with ALS. Understanding the effects of SOD1 mutations on protein structure and function facilitates the design of further experiments and provides relevant information on the molecular mechanism of pathology, which may contribute to improvements in existing treatments for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Gabriel Rodrigues Coutinho</ForeName><Initials>GRC</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Biology, Bioinformatics and Computational Biology Laboratory, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>B&#xe1;rbara de Azevedo Abrahim</ForeName><Initials>BAA</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Mesquita</LastName><ForeName>Joelma Freire</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0003-1684-3830</Identifier><AffiliationInfo><Affiliation>Department of Genetics and Molecular Biology, Bioinformatics and Computational Biology Laboratory, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030562" MajorTopicYN="N">Databases, Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: GRCP received material support from NVIDIA for this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>25</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33630959</ArticleId><ArticleId IdType="pmc">PMC7906464</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0247841</ArticleId><ArticleId IdType="pii">PONE-D-20-31045</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tao QQ, Wu ZY. Amyotrophic lateral sclerosis: Precise diagnosis and individualized treatment. Chin Med J (Engl). 2017;130: 2269&#x2013;2272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634073</ArticleId><ArticleId IdType="pubmed">28937029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano P, et al.. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6: 171. 10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al.. Amyotrophic lateral sclerosis. Lancet. 2017;390: 2084&#x2013;2098. 10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman M, Dharamshi C, Zinman L. Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses. Amyotroph Lateral Scler Front Degener. 2014;15: 426&#x2013;432. 10.3109/21678421.2014.932382</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.932382</ArticleId><ArticleId IdType="pubmed">25025935</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic Lateral Sclerosis Mimic Syndromes. Arch Neurol. 2000;57: 109. 10.1001/archneur.57.1.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.57.1.109</ArticleId><ArticleId IdType="pubmed">10634456</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, Calvo A, Price TR, Geiger JT, Chi&#xf2; A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7: 1&#x2013;6. 10.1038/ncomms12408</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipi T, Hermanova Z, Tureckova J, Vanatko O, Anderova M. Glial Cells&#x2014;The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. J Clin Med. 2020;9: 261. 10.3390/jcm9010261</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9010261</ArticleId><ArticleId IdType="pmc">PMC7020059</ArticleId><ArticleId IdType="pubmed">31963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med Res Rev. 2018. 10.1002/med.21528</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017;10: 499&#x2013;502. 10.1242/dmm.030205</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.030205</ArticleId><ArticleId IdType="pmc">PMC5451177</ArticleId><ArticleId IdType="pubmed">28468935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Navarro X. Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic. Prog Neurobiol. 2015;133: 1&#x2013;26. 10.1016/j.pneurobio.2015.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.07.004</ArticleId><ArticleId IdType="pubmed">26253783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hyeon SJ, Im H, Ryu H, Kim Y, Ryu H. Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp Neurobiol. 2016;25: 233&#x2013;240. 10.5607/en.2016.25.5.233</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker AM, Seelen M, van Doormaal PTC, van Rheenen W, Bothof RJP, van Riessen T, et al.. Large-scale screening in sporadic amyotrophic lateral sclerosis identifies genetic modifiers in C9orf72 repeat carriers. Neurobiol Aging. 2016;39: 220.e9&#x2013;220.e15. 10.1016/j.neurobiolaging.2015.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.12.012</ArticleId><ArticleId IdType="pubmed">26777436</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Ma Y, Liu XL, Chen L, Fan DS. Better survival in female SOD1-mutant patients with ALS: A study of SOD1-related natural history. Transl Neurodegener. 2019;8: 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423817</ArticleId><ArticleId IdType="pubmed">30923611</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-sureda V, Vilches &#xc1;, S&#xe1;nchez O, Aud&#xed; L, Dom&#xed;nguez C. Intracellular Oxidant Activity, Antioxidant Enzyme Defense System, and Cell Senescence in Fibroblasts with Trisomy 21. Oxid Med Cell Longev. 2015;2015: 17. 10.1155/2015/509241</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/509241</ArticleId><ArticleId IdType="pmc">PMC4380103</ArticleId><ArticleId IdType="pubmed">25852816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577: 109&#x2013;118. 10.1016/j.gene.2015.11.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira GRC, Da Silva ANR, Do Nascimento SS, De Mesquita JF. In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variants. J Cell Biochem. 2019;120: 3583&#x2013;3598. 10.1002/jcb.27636</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.27636</ArticleId><ArticleId IdType="pubmed">30206983</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ara&#xfa;jo Brasil A, de Carvalho MDC, Gerhardt E, Queiroz DD, Pereira MD, Outeiro TF, et al.. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proc Natl Acad Sci U S A. 2019;116: 25991&#x2013;26000. 10.1073/pnas.1902483116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1902483116</ArticleId><ArticleId IdType="pmc">PMC6926019</ArticleId><ArticleId IdType="pubmed">31796595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C. Sod1 in amyotrophic lateral sclerosis: &#x201c;ambivalent&#x201d; behavior connected to the disease. Int J Mol Sci. 2018;19: 1&#x2013;13. 10.3390/ijms19051345</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira GRC, Tavares GDB, De Freitas MC, De Mesquita JF. In silico analysis of the tryptophan hydroxylase 2 (TPH2) protein variants related to psychiatric disorders. PLoS One. 2020;15: 1&#x2013;23. 10.1371/journal.pone.0229730</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0229730</ArticleId><ArticleId IdType="pmc">PMC7051086</ArticleId><ArticleId IdType="pubmed">32119710</ArticleId></ArticleIdList></Reference><Reference><Citation>De Oliveira CCS, Pereira GRC, De Alcantara JYS, Antunes D, Caffarena ER, De Mesquita JF. In silico analysis of the V66M variant of human BDNF in psychiatric disorders: An approach to precision medicine. PLoS One. 2019;14: e0215508. 10.1371/journal.pone.0215508</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0215508</ArticleId><ArticleId IdType="pmc">PMC6472887</ArticleId><ArticleId IdType="pubmed">30998730</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva ANR, Pereira GRC, Moreira LGA, Rocha CF, Mesquita JF. SOD1 in amyotrophic lateral sclerosis development&#x2013;in silico analysis and molecular dynamics of A4F and A4V variants. J Cell Biochem. 2019; 1&#x2013;9. 10.1002/jcb.29048</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.29048</ArticleId><ArticleId IdType="pubmed">31134679</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira GRC, Tellini GHAS, De Mesquita JF. In silico analysis of PFN1 related to amyotrophic lateral sclerosis. PLOS ONE. 2019;14: e0215723. 10.1371/journal.pone.0215723</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0215723</ArticleId><ArticleId IdType="pmc">PMC6583998</ArticleId><ArticleId IdType="pubmed">31216283</ArticleId></ArticleIdList></Reference><Reference><Citation>Thusberg J, Vihinen M. Pathogenic or not? and if so, then how? Studying the effects of missense mutations using bioinformatics methods. Hum Mutat. 2009;30: 703&#x2013;714. 10.1002/humu.20938</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20938</ArticleId><ArticleId IdType="pubmed">19267389</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy Choudhury A, Cheng T, Phan L, Bryant SH, Wang Y. Supporting precision medicine by data mining across multi-disciplines: An integrative approach for generating comprehensive linkages between single nucleotide variants (SNVs) and drug-binding sites. Bioinformatics. 2017;33: 1621&#x2013;1629. 10.1093/bioinformatics/btx031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx031</ArticleId><ArticleId IdType="pmc">PMC5856083</ArticleId><ArticleId IdType="pubmed">28158543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose PW, Prli&#x107; A, Altunkaya A, Bi C, Bradley AR, Christie CH, et al.. The RCSB protein data bank: Integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017;45: D271&#x2013;D281. 10.1093/nar/gkw1000</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1000</ArticleId><ArticleId IdType="pmc">PMC5210513</ArticleId><ArticleId IdType="pubmed">27794042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman A, Martin MJ, O&#x2019;Donovan C, Magrane M, Alpi E, Antunes R, et al.. UniProt: The universal protein knowledgebase. Nucleic Acids Res. 2017;45: D158&#x2013;D169. 10.1093/nar/gkw1099</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1099</ArticleId><ArticleId IdType="pmc">PMC5210571</ArticleId><ArticleId IdType="pubmed">27899622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler DL, Chappey C, Lash a E, Leipe DD, Madden TL, Schuler GD, et al.. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2000;28: 10&#x2013;4. 10.1093/nar/28.1.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.10</ArticleId><ArticleId IdType="pmc">PMC102437</ArticleId><ArticleId IdType="pubmed">10592169</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat. 2012;33: 1345&#x2013;1351. 10.1002/humu.22157</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry ST. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29: 308&#x2013;311. 10.1093/nar/29.1.308</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.1.308</ArticleId><ArticleId IdType="pmc">PMC29783</ArticleId><ArticleId IdType="pubmed">11125122</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al.. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46: D1062&#x2013;D1067. 10.1093/nar/gkx1153</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1153</ArticleId><ArticleId IdType="pmc">PMC5753237</ArticleId><ArticleId IdType="pubmed">29165669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al.. PANTHER version 11: Expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45: D183&#x2013;D189. 10.1093/nar/gkw1138</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1138</ArticleId><ArticleId IdType="pmc">PMC5210595</ArticleId><ArticleId IdType="pubmed">27899595</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Chan AP. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31: 2745&#x2013;2747. 10.1093/bioinformatics/btv195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv195</ArticleId><ArticleId IdType="pmc">PMC4528627</ArticleId><ArticleId IdType="pubmed">25851949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, et al.. PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations. PLoS Comput Biol. 2014;10: 1&#x2013;11. 10.1371/journal.pcbi.1003440</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003440</ArticleId><ArticleId IdType="pmc">PMC3894168</ArticleId><ArticleId IdType="pubmed">24453961</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrahari AK, Sneha P, George Priya Doss C, Siva R, Zayed H. A profound computational study to prioritize the disease-causing mutations in PRPS1 gene. Metab Brain Dis. 2018;33: 589&#x2013;600. 10.1007/s11011-017-0121-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-017-0121-2</ArticleId><ArticleId IdType="pubmed">29047041</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira LGA, Pereira LC, Drummond PR, De Mesquita JF, Andersen P, Phukan J, et al.. Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis. Le W, editor. PLoS One. 2013;8: e81979. 10.1371/journal.pone.0081979</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081979</ArticleId><ArticleId IdType="pmc">PMC3846731</ArticleId><ArticleId IdType="pubmed">24312616</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho MDC, De Mesquita JF. Structural Modeling and In Silico Analysis of Human Superoxide Dismutase 2. PLoS One. 2013;8. 10.1371/journal.pone.0065558</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065558</ArticleId><ArticleId IdType="pmc">PMC3681941</ArticleId><ArticleId IdType="pubmed">23785434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T, et al.. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016;44: 344&#x2013;350. 10.1093/nar/gkw408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw408</ArticleId><ArticleId IdType="pmc">PMC4987940</ArticleId><ArticleId IdType="pubmed">27166375</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: Fast, flexible, and free. J Comput Chem. 2005;26: 1701&#x2013;1718. 10.1002/jcc.20291</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20291</ArticleId><ArticleId IdType="pubmed">16211538</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistini S, Benigni M, Ricci C, Rossi A. SOD1 mutations in amyotrophic lateral sclerosis. Eur Neurol J. 2010;000: 1&#x2013;11. Available: http://link.springer.com/article/10.1007/s00415-005-0742-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0742-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD. Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics. 2006;22: 2695&#x2013;2696. 10.1093/bioinformatics/btl461</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btl461</ArticleId><ArticleId IdType="pubmed">16940322</ArticleId></ArticleIdList></Reference><Reference><Citation>Keerthana SP, Kolandaivel P. Structural investigation on the electrostatic loop of native and mutated SOD1 and their interaction with therapeutic compounds. RSC Adv. 2015;5: 34630&#x2013;34644. 10.1039/C5RA00286A</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5RA00286A</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E, Rajasekaran R. Computational Investigation on Electrostatic Loop Mutants Instigating Destabilization and Aggregation on Human SOD1 Protein Causing Amyotrophic Lateral Sclerosis. Protein J. 2019;38: 37&#x2013;49. 10.1007/s10930-018-09809-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-018-09809-0</ArticleId><ArticleId IdType="pubmed">30701485</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirangelo I, Iannuzzi C. The role of metal binding in the amyotrophic lateral sclerosis-related aggregation of copper-zinc superoxide dismutase. Molecules. 2017;22: 1&#x2013;13. 10.3390/molecules22091429</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22091429</ArticleId><ArticleId IdType="pmc">PMC6151412</ArticleId><ArticleId IdType="pubmed">28850080</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E, Sethumadhavan R, Rajasekaran R. A theoretical study on Zn binding loop mutants instigating destabilization and metal binding loss in human SOD1 protein. J Mol Model. 2017;23: 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28271284</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp B, Frantal S, Cibena M, Schreiner W, Bauer P. Is an intuitive convergence definition of molecular dynamics simulations solely based on the root mean square deviation possible? J Comput Biol. 2011;18: 997&#x2013;1005. 10.1089/cmb.2010.0237</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cmb.2010.0237</ArticleId><ArticleId IdType="pmc">PMC3145956</ArticleId><ArticleId IdType="pubmed">21702691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99: 1129&#x2013;1143. 10.1016/j.neuron.2018.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.08.011</ArticleId><ArticleId IdType="pmc">PMC6209097</ArticleId><ArticleId IdType="pubmed">30236283</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez L. Automatic Identification of Mobile and Rigid Substructures in Molecular Dynamics Simulations and Fractional Structural Fluctuation Analysis. Kleinjung J, editor. PLoS One. 2015;10: e0119264. 10.1371/journal.pone.0119264</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119264</ArticleId><ArticleId IdType="pmc">PMC4376797</ArticleId><ArticleId IdType="pubmed">25816325</ArticleId></ArticleIdList></Reference><Reference><Citation>Craveur P, Joseph AP, Esque J, Narwani TJ, No&#xeb;l F, Shinada N, et al.. Protein flexibility in the light of structural alphabets. Front Mol Biosci. 2015;2. 10.3389/fmolb.2015.00020</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2015.00020</ArticleId><ArticleId IdType="pmc">PMC4445325</ArticleId><ArticleId IdType="pubmed">26075209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzmanic A, Zagrovic B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys J. 2010;98: 861&#x2013;871. 10.1016/j.bpj.2009.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2009.11.011</ArticleId><ArticleId IdType="pmc">PMC2830444</ArticleId><ArticleId IdType="pubmed">20197040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z, Bailey TL, Teasdale RD. Prediction of protein B-factor profiles. Proteins Struct Funct Genet. 2005;58: 905&#x2013;912. 10.1002/prot.20375</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.20375</ArticleId><ArticleId IdType="pubmed">15645415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang P, Hu W, Ye YJ, Li LH, Zhang C, Xie YH, et al.. In silico screening, molecular docking, and molecular dynamics studies of SNP-derived human P5CR mutants. Journal of Biomolecular Structure and Dynamics. 2017. 10.1080/07391102.2016.1222967</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2016.1222967</ArticleId><ArticleId IdType="pubmed">27677826</ArticleId></ArticleIdList></Reference><Reference><Citation>David CC, Jacobs DJ. Principal Component Analysis: A Method for Determining the Essential Dynamics of Proteins Article. Proteins. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676806</ArticleId><ArticleId IdType="pubmed">24061923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SAM, Loccisano AE, Firestine SM, Evanseck JD. Principal Components Analysis: A Review of its Application on Molecular Dynamics Data. Annual Reports in Computational Chemistry. 2006. pp. 233&#x2013;248.</Citation></Reference><Reference><Citation>Khan FI, Wei DQ, Gu KR, Hassan MI, Tabrez S. Current updates on computer aided protein modeling and designing. Int J Biol Macromol. 2016;85: 48&#x2013;62. 10.1016/j.ijbiomac.2015.12.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2015.12.072</ArticleId><ArticleId IdType="pubmed">26730484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Verma S, Singh A, Somvanshi P, Grover A. Simulation Based Investigation of Deleterious nsSNPs in ATXN2 Gene and Its Structural Consequence Toward Spinocerebellar Ataxia. J Cell Biochem. 2018;119: 499&#x2013;510. 10.1002/jcb.26209</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26209</ArticleId><ArticleId IdType="pubmed">28612427</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Mehmood A, Wang H, Xu Q, Xiong Y, Wei DQ. Computational screening and analysis of lung cancer related non-synonymous single nucleotide polymorphisms on the human kirsten rat sarcoma gene. Molecules. 2019;24. 10.3390/molecules24101951</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24101951</ArticleId><ArticleId IdType="pmc">PMC6572712</ArticleId><ArticleId IdType="pubmed">31117243</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M, Ronchi D, Keskin I, Basak AN, Wilhelm C, Gobbi C, et al.. Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Hum Mol Genet. 2012;21: 3568&#x2013;3574. 10.1093/hmg/dds188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds188</ArticleId><ArticleId IdType="pubmed">22595972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Rahman S, Choudhry H, Zamzami MA, Sarwar Jamal M, Islam A, et al.. Computing disease-linked SOD1 mutations: Deciphering protein stability and patient-phenotype relations article. Sci Rep. 2017;7: 1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498623</ArticleId><ArticleId IdType="pubmed">28680046</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymkowitz JWH, Rousseau F, Martins IC, Ferkinghoff-Borg J, Stricher F, Serrano L. Prediction of water and metal binding sites and their affinities by using the Fold-X force field. Proc Natl Acad Sci U S A. 2005;102: 10147&#x2013;10152. 10.1073/pnas.0501980102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501980102</ArticleId><ArticleId IdType="pmc">PMC1177371</ArticleId><ArticleId IdType="pubmed">16006526</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33: W306&#x2013;W310. 10.1093/nar/gki375</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki375</ArticleId><ArticleId IdType="pmc">PMC1160136</ArticleId><ArticleId IdType="pubmed">15980478</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BF, Durazo A, Nersissian AM, Whitelegge JP, Faull KF, Valentine JS. Local unfolding in a destabilized, pathogenic variant of superoxide dismutase 1 observed with H/D exchange and mass spectrometry. J Biol Chem. 2006;281: 18167&#x2013;18176. 10.1074/jbc.M600623200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M600623200</ArticleId><ArticleId IdType="pubmed">16644738</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg DS. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis*. 2013;1: 362&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">28132491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough MA, Grossmann JG, Antonyuk S V, Strange RW, Doucette PA, Rodriguez JA, et al.. Dimer destabilization in superoxide dismutase may result in disease-causing properties: Structures of motor neuron disease mutants. PNAS. 2004;101: 5976&#x2013;5981. 10.1073/pnas.0305143101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0305143101</ArticleId><ArticleId IdType="pmc">PMC395908</ArticleId><ArticleId IdType="pubmed">15056757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA, Valentine JS, Eggers DK, Roe JA, Tiwari A, Brown RH, et al.. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J Biol Chem. 2002;277: 15932&#x2013;15937. 10.1074/jbc.M112088200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112088200</ArticleId><ArticleId IdType="pubmed">11854285</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Andersen PM, Marklund SL, Br&#xe4;nnstr&#xf6;m T. Superoxide dismutase in amyotrophic lateral sclerosis patients homozygous for the D90A mutation. Neurobiol Dis. 2009;36: 421&#x2013;424. 10.1016/j.nbd.2009.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.006</ArticleId><ArticleId IdType="pubmed">19703565</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler DD, Schuermann JP, Cao X, Holloway SP, Borchelt DR, Carroll MC, et al.. Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q. Biochemistry. 2009;48: 3436&#x2013;3447. 10.1021/bi8021735</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi8021735</ArticleId><ArticleId IdType="pmc">PMC2757159</ArticleId><ArticleId IdType="pubmed">19227972</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonyuk S, Elam JS, Hough MA, Strange RW, Doucette PA, Rodriguez JA, et al.. Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg. Protein Sci. 2005;14: 1201&#x2013;1213. 10.1110/ps.041256705</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.041256705</ArticleId><ArticleId IdType="pmc">PMC2253262</ArticleId><ArticleId IdType="pubmed">15840828</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt ND, Agar JN. Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS. J Mass Spectrom. 2017;52: 480&#x2013;491. 10.1002/jms.3953</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.3953</ArticleId><ArticleId IdType="pmc">PMC6002871</ArticleId><ArticleId IdType="pubmed">28558143</ArticleId></ArticleIdList></Reference><Reference><Citation>Auclair JR, Boggio KJ, Petsko GA, Ringe D, Agar JN. Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2010;107: 21394&#x2013;21399. 10.1073/pnas.1015463107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1015463107</ArticleId><ArticleId IdType="pmc">PMC3003092</ArticleId><ArticleId IdType="pubmed">21098299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright GSA, Antonyuk S V., Kershaw NM, Strange RW, Samar Hasnain S. Ligand binding and aggregation of pathogenic SOD1. Nat Commun. 2013;4: 1710&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3644087</ArticleId><ArticleId IdType="pubmed">23612299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova MI, Sievers SA, Guenther EL, Johnson LM, Winkler DD, Galaleldeen A, et al.. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc Natl Acad Sci U S A. 2014;111: 197&#x2013;201. 10.1073/pnas.1320786110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320786110</ArticleId><ArticleId IdType="pmc">PMC3890817</ArticleId><ArticleId IdType="pubmed">24344300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala FA, Wright GSA, Antonyuk S V., Garratt RC, Hasnain SS. Molecular recognition and maturation of sod1 by its evolutionarily destabilised cognate chaperone hCCS. PLoS Biol. 2019;17: 1&#x2013;22. 10.1371/journal.pbio.3000141</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000141</ArticleId><ArticleId IdType="pmc">PMC6383938</ArticleId><ArticleId IdType="pubmed">30735496</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, et al.. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: Genotype-phenotype correlations. J Med Genet. 2010;47: 554&#x2013;560. 10.1136/jmg.2010.077180</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2010.077180</ArticleId><ArticleId IdType="pubmed">20577002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira A, Da R, Rodrigues G, Pereira C. SOD1 in amyotrophic lateral sclerosis development&#x2013;in silico analysis and molecular dynamics of A4F and A4V variants. 2019; 1&#x2013;9. 10.1002/jcb.29048</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.29048</ArticleId><ArticleId IdType="pubmed">31134679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Chakrabartty A. Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochim Biophys Acta&#x2014;Mol Basis Dis. 2006;1762: 1025&#x2013;1037. 10.1016/j.bbadis.2006.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.004</ArticleId><ArticleId IdType="pubmed">16814528</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A, Plotkin SS. Mechanical probes of SOD1 predict systematic trends in metal and dimer affinity of ALS-associated mutants. J Mol Biol. 2013;425: 850&#x2013;874. 10.1016/j.jmb.2012.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2012.12.022</ArticleId><ArticleId IdType="pubmed">23291526</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd SD, Ullrich MS, Calvo JS, Behnia F, Meloni G, Winkler DD. Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs) Stefanie. Molecules. 2020;25: 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179120</ArticleId><ArticleId IdType="pubmed">32121118</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo V, Ventura S. Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases. PLoS Comput Biol. 2009;5. 10.1371/journal.pcbi.1000476</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000476</ArticleId><ArticleId IdType="pmc">PMC2719061</ArticleId><ArticleId IdType="pubmed">19696882</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, Bertolotti A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J Mol Biol. 2010;399: 512&#x2013;525. 10.1016/j.jmb.2010.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2010.04.019</ArticleId><ArticleId IdType="pmc">PMC2927901</ArticleId><ArticleId IdType="pubmed">20399791</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Aquilina JA, Yerbury JJ. Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity. Front Neurosci. 2016;10: 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095133</ArticleId><ArticleId IdType="pubmed">27867347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Hong RH, Mackenzie IR, Cashman NR. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS One. 2017;12: 1&#x2013;10. 10.1371/journal.pone.0184384</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184384</ArticleId><ArticleId IdType="pmc">PMC5587256</ArticleId><ArticleId IdType="pubmed">28877271</ArticleId></ArticleIdList></Reference><Reference><Citation>Oztug Durer ZA, Cohlberg JA, Dinh P, Padua S, Ehrenclou K, Downes S, et al.. Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase. PLoS One. 2009;4. 10.1371/journal.pone.0005004</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005004</ArticleId><ArticleId IdType="pmc">PMC2659422</ArticleId><ArticleId IdType="pubmed">19325915</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Boca M, Girotto S, Martinelli M, Valentine JS, et al.. SOD1 and amyotrophic lateral sclerosis: Mutations and oligomerization. PLoS One. 2008;3: 1&#x2013;8. 10.1371/journal.pone.0001677</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001677</ArticleId><ArticleId IdType="pmc">PMC2250751</ArticleId><ArticleId IdType="pubmed">18301754</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BF, Valentine JS. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci. 2007;32: 78&#x2013;85. 10.1016/j.tibs.2006.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2006.12.005</ArticleId><ArticleId IdType="pubmed">17208444</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7. 10.3389/fncel.2013.00253</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonyuk S V., Strange RW, Marklund SL, Hasnain SS. The Structure of Human Extracellular Copper-Zinc Superoxide Dismutase at 1.7 &#xc5; Resolution: Insights into Heparin and Collagen Binding. J Mol Biol. 2009;388: 310&#x2013;326. 10.1016/j.jmb.2009.03.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2009.03.026</ArticleId><ArticleId IdType="pubmed">19289127</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemasov NA, Ivanisenko N V., Ramachandran S, Ivanisenko VA. Molecular mechanisms underlying the impact of mutations in SOD1 on its conformational properties associated with amyotrophic lateral sclerosis as revealed with molecular modelling. BMC Struct Biol. 2018;18: 1&#x2013;14. 10.1186/s12900-018-0080-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12900-018-0080-9</ArticleId><ArticleId IdType="pmc">PMC5808480</ArticleId><ArticleId IdType="pubmed">29431095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Zhou Q, Chen Y, Ou R, Cao B, Xu Y, et al.. Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: A case-control study and literature review. Sci Rep. 2017;7: 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5349524</ArticleId><ArticleId IdType="pubmed">28291249</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrey C, Douglas JF, Gilson MK. The fundamental role of flexibility on the strength of molecular binding. Soft Matter. 2012;8: 6385&#x2013;6392. 10.1039/C2SM25160D</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C2SM25160D</ArticleId><ArticleId IdType="pmc">PMC3374587</ArticleId><ArticleId IdType="pubmed">22707976</ArticleId></ArticleIdList></Reference><Reference><Citation>Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, et al.. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol. 2003;10: 461&#x2013;467. 10.1038/nsb935</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb935</ArticleId><ArticleId IdType="pubmed">12754496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayama K, Fujiwara Y, Terada T, Shimizu K, Wada K, Kabuta T. Virtual screening identification of novel chemical inhibitors for aberrant interactions between pathogenic mutant SOD1 and tubulin. Neurochem Int. 2019;126: 19&#x2013;26. 10.1016/j.neuint.2019.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.02.020</ArticleId><ArticleId IdType="pubmed">30831216</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkler C, O&#x2019;Neil AL, Slepian S, Qian F, Weinreb PH, Rubin LL. Aggregated SOD1 causes selective death of cultured human motor neurons. Sci Rep. 2018;8: 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6219543</ArticleId><ArticleId IdType="pubmed">30401824</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, D&#x2019;Amelio N, Gaggelli E, Libralesso E, Matecko I, et al.. Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution. J Biol Chem. 2005;280: 35815&#x2013;35821. 10.1074/jbc.M506637200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506637200</ArticleId><ArticleId IdType="pubmed">16105836</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt ND, Agar JN. Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS. J Mass Spectrom. 2017;52: 480&#x2013;491. 10.1002/jms.3953</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.3953</ArticleId><ArticleId IdType="pmc">PMC6002871</ArticleId><ArticleId IdType="pubmed">28558143</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar KS, Karabacak NM, Johnson JL, Wang Q, Tiwari A, Hayward LJ, et al.. A common property of amyotrophic lateral sclerosis-associated variants. Destabilization of the copper/zinc superoxide dismutase electrostatic loop. J Biol Chem. 2009;284: 30965&#x2013;30973. 10.1074/jbc.M109.023945</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.023945</ArticleId><ArticleId IdType="pmc">PMC2781497</ArticleId><ArticleId IdType="pubmed">19635794</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs BB, De Mesquita JF, Robberecht W, Philips T, Mancuso R, Navarro X, et al.. Amyotrophic Lateral Sclerosis Type 20&#x2014;In Silico Analysis and Molecular Dynamics Simulation of hnRNPA1. PLoS One. 2016. 10.1371/journal.pone.0158939</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0158939</ArticleId><ArticleId IdType="pmc">PMC4945010</ArticleId><ArticleId IdType="pubmed">27414033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Quartier C, Jeanquartier F, Jurisica I, Holzinger A. In silico cancer research towards 3R. BMC Cancer. 2018;18: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5897933</ArticleId><ArticleId IdType="pubmed">29649981</ArticleId></ArticleIdList></Reference><Reference><Citation>Raies AB, Bajic VB. In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci. 2016;6: 147&#x2013;172. 10.1002/wcms.1240</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wcms.1240</ArticleId><ArticleId IdType="pmc">PMC4785608</ArticleId><ArticleId IdType="pubmed">27066112</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Str&#xf6;m AL, Fukada K, Lee S, Hayward LJ, Zhu H. Interaction between familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem. 2007;282: 16691&#x2013;16699. 10.1074/jbc.M609743200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609743200</ArticleId><ArticleId IdType="pubmed">17403682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>